Drug Patents owned by Otter Pharms
1. Drug name - OTREXUP
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9533102 | OTTER PHARMS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US9629959 | OTTER PHARMS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US8562564 | OTTER PHARMS | Prefilled syringe jet injector |
Jan, 2026
(3 years from now) | |
| US8021335 | OTTER PHARMS | Prefilled syringe jet injector |
Oct, 2026
(3 years from now) | |
| US9867949 | OTTER PHARMS | Injector safety device |
Mar, 2029
(6 years from now) | |
| US10709844 | OTTER PHARMS | Injector safety device |
Mar, 2029
(6 years from now) | |
| US9421333 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(7 years from now) | |
| US8945063 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(7 years from now) | |
| US8579865 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(7 years from now) | |
| US8480631 | OTTER PHARMS | Hazardous agent injection system |
Mar, 2030
(7 years from now) | |
| US8814834 | OTTER PHARMS | Injector safety device |
May, 2031
(8 years from now) | |
Drugs and Companies using METHOTREXATE ingredient
Treatment: Subcutaneous injection of methotrexate
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 7.5MG/0.4ML (7.5MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 10MG/0.4ML (10MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 12.5MG/0.4ML (12.5MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 15MG/0.4ML (15MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 17.5MG/0.4ML (17.5MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 20MG/0.4ML (20MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 22.5MG/0.4ML (22.5MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 25MG/0.4ML (25MG/0.4ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 15MG/0.6ML (15MG/0.6ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 17.5MG/0.7ML (17.5MG/0.7ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 20MG/0.8ML (20MG/0.8ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 22.5MG/0.9ML (22.5MG/0.9ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
| 25MG/ML (25MG/ML) | SOLUTION;SUBCUTANEOUS | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.